Buy Stocks Easy | About Us
June 28, 2022
Buy Stocks Easy | Online Stocks

ALIM


Buy Alimera Sciences, Inc. Stock (symbol: ALIM) Easy Online

Company Name: Alimera Sciences, Inc.

Symbol: ALIM

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2010

ALIM Current Share Price

Today's ALIM ( Alimera Sciences, Inc. ) opening price: $7.3800

Yesterday's ALIM ( Alimera Sciences, Inc. ) closing price: $7.2400

Alimera Sciences, Inc. Stock ( symbol: ALIM ) Price Chart since IPO (2010):

12 Months Alimera Sciences, Inc. Stock ( symbol: ALIM ) Price Chart

Popular Questions about Alimera Sciences, Inc. Public Stock ( ALIM )

A: Alimera Sciences, Inc. stock symbol (also called stock or share ticker) is ALIM

A: Alimera Sciences, Inc. IPO (Initial Public Offering) took place on 2010

A: Alimera Sciences, Inc.'s stock (ALIM symbol) price at ther IPO (initial Public Offering) was $7.3800

Q: Is ALIM stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Alimera Sciences, Inc. stock (symbol: ALIM) at the beginning of 2019, at the opening share price of $0.9797, with a minimum of $200, by now your shares would be worth $41028 and your profit would be $40828 - SHOW ONLY IF PROFIT.

Buy Alimera Sciences, Inc. Stock Easy Online

Alimera Sciences, Inc. Stock Ticker Price Chart since IPO:





Alimera Sciences, Inc. Stock Price Yesterday



 


Alimera Sciences, Inc. Stock Price – Last Week




 


Alimera Sciences, Inc. Stock Price – Last Month




 


Alimera Sciences, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/03/1955538/0/en/Alimera-Announces-Regulatory-Approval-for-ILUVIEN-in-Benelux-Countries-for-The-Treatment-of-Non-Infectious-Posterior-Uveitis.html
                            

                                
Alimera Announces Regulatory Approval for ILUVIEN® in Benelux Countries for The Treatment of Non-Infectious Posterior Uveitis

                                
                                
Company continues to execute on its international expansion strategy


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/14/1947494/0/en/Alimera-Sciences-Announces-Effectiveness-of-Previously-Announced-Reverse-Stock-Split.html
                            

                                
Alimera Sciences Announces Effectiveness of Previously Announced Reverse Stock Split

                                
                                
ATLANTA, Nov.  14, 2019  (GLOBE NEWSWIRE) -- Alimera Sciences, Inc....


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/07/1943690/0/en/Alimera-Sciences-Announces-Board-s-Approval-of-Reverse-Stock-Split-Ratio.html
                            

                                
Alimera Sciences Announces Board’s Approval of Reverse Stock Split Ratio

                                
                                
ATLANTA, Nov.  07, 2019  (GLOBE NEWSWIRE) -- Alimera Sciences, Inc....


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/05/1941181/0/en/Alimera-Sciences-to-Participate-in-the-10th-Annual-Craig-Hallum-Alpha-Select-Conference-in-New-York.html
                            

                                
Alimera Sciences to Participate in the 10th Annual Craig-Hallum Alpha Select Conference in New York

                                
                                
ATLANTA, Nov.  05, 2019  (GLOBE NEWSWIRE) -- Alimera Sciences, Inc....


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4300446-alimera-sciences-inc-alim-ceo-richard-eiswirth-q3-2019-results-earnings-call-transcript
                            

                                
Alimera Sciences, Inc. (ALIM) CEO Richard Eiswirth on Q3 2019 Results - Earnings Call Transcript

                                
                                
Alimera Sciences, Inc. (ALIM) CEO Richard Eiswirth on Q3 2019 Resul...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/29/1937486/0/en/Alimera-Sciences-Announces-Third-Quarter-2019-Financial-Results-and-Provides-Corporate-Update.html
                            

                                
Alimera Sciences Announces Third Quarter 2019 Financial Results and Provides Corporate Update

                                
                                
Third Quarter and Recent Company Highlights:


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/25/1935679/0/en/Alimera-Sciences-Announces-Equity-Purchase-Agreement-for-up-to-20-Million-with-Lincoln-Park-Capital.html
                            

                                
Alimera Sciences Announces Equity Purchase Agreement for up to $20 Million with Lincoln Park Capital

                                
                                
ATLANTA, Oct.  25, 2019  (GLOBE NEWSWIRE) -- Alimera Sciences, Inc....


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/23/1934087/0/en/Alimera-Sciences-to-Report-Third-Quarter-2019-Financial-Results-on-Tuesday-October-29-2019-and-Provide-Corporate-Update.html
                            

                                
Alimera Sciences to Report Third Quarter 2019 Financial Results on Tuesday, October 29, 2019 and Provide Corporate Update

                                
                                
Conference Call to be held Wednesday, October 30, 2019 at 9:00am Ea...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/02/1924043/0/en/Alimera-Sciences-Announces-Top-Line-Revenue-Expectation-For-the-Third-Quarter-of-2019.html
                            

                                
Alimera Sciences Announces Top Line Revenue Expectation For the Third Quarter of 2019

                                
                                
Consolidated net revenue expected to exceed $12.8 million Consolida...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/05/1911461/0/en/Alimera-Sciences-Board-of-Directors-Approves-Reverse-Stock-Split-and-10b5-1-Stock-Purchase-Plan-for-U-S-Executive-Management.html
                            

                                
Alimera Sciences Board of Directors Approves Reverse Stock Split and  10b5-1 Stock Purchase Plan for U.S. Executive Management

                                
                                
ATLANTA, Sept.  05, 2019  (GLOBE NEWSWIRE) -- Alimera Sciences, Inc...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.